Non-exhaustive listing of clinical trial performance metrics initiatives
Since we started, with Evidence, to talk about performance metrics in the clinical environment, I’m trying to obtain a clear picture of the active actors in this domain of expertise.
After few months, it becomes clear to me that it is not so easy to obtain this picture perhaps because we are facing a really emerging market with very few initiatives so far. Nevertheless, I think that this type of information could be very valuable for everyone in the community who shares our interest in this matter.
No commentsClinical Trial Performance - why should we assess it?
Have you ever been asked to “reduce the costs to develop new pharmaceutical products and / or to reduce time to market”? Yes? Then you will be interested in sharing your experience and ideas on this matter!
No comments
